Carbon monoxide derived from heme oxygenase-2 mediates reduction of methylmercury toxicity in SH-SY5Y cells

Toxicol Appl Pharmacol. 2010 Nov 15;249(1):86-90. doi: 10.1016/j.taap.2010.08.021. Epub 2010 Aug 31.

Abstract

We examined the contribution of carbon monoxide (CO), an enzymatic product of heme oxygenase (HO), to methylmercury (MeHg) cytotoxicity in SH-SY5Y cells, because this gas molecule is reported to activate Nrf2, which plays a protective role against MeHg-mediated cell damage. Exposure of SH-SY5Y cells to CO gas resulted in protection against MeHg cytotoxicity, with activation of Nrf2. Interestingly, pretreatment with tin-protoporphyrin IX, a specific inhibitor of HO, caused a reduction in basal Nrf2 activity and thus enhanced sensitivity to MeHg. No induction of isoform 1 of HO (HO-1) was seen during MeHg exposure, but constitutive expression of isoform 2 (HO-2) occurred, suggesting that CO produced by HO-2 is the main participant in the protection against MeHg toxicity. Studies of small interfering RNA-mediated knockdown of HO-2 in the cells supported this possibility. Our results suggest that CO gas and its producing enzyme HO-2 are key molecules in cellular protection against MeHg, presumably through basal activation of Nrf2.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carbon Monoxide / physiology*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Cytoprotection / drug effects
  • Cytoprotection / physiology*
  • Heme Oxygenase (Decyclizing) / metabolism*
  • Heme Oxygenase (Decyclizing) / physiology
  • Humans
  • Methylmercury Compounds / antagonists & inhibitors
  • Methylmercury Compounds / toxicity*
  • NF-E2-Related Factor 2 / metabolism

Substances

  • Methylmercury Compounds
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human
  • Carbon Monoxide
  • Heme Oxygenase (Decyclizing)
  • heme oxygenase-2